Raymond James & Associates Stevanato Group S.P.A. Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Stevanato Group S.P.A. stock. As of the latest transaction made, Raymond James & Associates holds 281,455 shares of STVN stock, worth $6.31 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
281,455
Previous 231,075
21.8%
Holding current value
$6.31 Million
Previous $4.24 Million
32.85%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding STVN
# of Institutions
131Shares Held
55.3MCall Options Held
2.7KPut Options Held
1K-
Conestoga Capital Advisors, LLC8.08MShares$181 Million2.35% of portfolio
-
Neuberger Berman Group LLC New York, NY4.56MShares$102 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.74MShares$83.9 Million0.05% of portfolio
-
Times Square Capital Management, LLC3.29MShares$73.7 Million1.1% of portfolio
-
Thrivent Financial For Lutherans Minneapolis, MN2.78MShares$62.4 Million0.11% of portfolio
About Stevanato Group S.p.A.
- Ticker STVN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 264,700,000
- Market Cap $5.93B
- Description
- Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...